BOULDER, Colo.--(BUSINESS WIRE)--Nov 8, 2023--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, announced today that members of its senior management team will participate in the following upcoming investor conferences:<em>Stifel 2023 ...
SAN DIEGO--(BUSINESS WIRE)--Nov 8, 2023--<a ...
--(BUSINESS WIRE)--Nov 8, 2023--<em>WHAT:</em> Serimmune will discuss its Serum Epitope Repertoire Analysis (SERA) platform and how it can be applied in various studies to gain insight into past and present humoral immune responses in individuals and cohorts. The new ...
AUSTIN, Texas--(BUSINESS WIRE)--Nov 8, 2023--<a ...
SANTA CRUZ, Calif. & CAMPBELL, Calif.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 8, 2023--Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to modulate the tumor microenvironment to elicit a potent and durable anti-tumor response, today announced that company leadership will present ...
